INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Helena Rebelo‐de‐Andrade, Lisa Licitra et al.|Clinical Cancer Research|2025Cited by 26
Clinical and morphological observation of a 19-year-old patient with alveolar rhabdomyosarcoma of the head and neck regionYu. E. Ryabukhina, I. N. Yurichev, А. М. Мудунов et al.|MD-Onco|2022Cited by 0
Supplementary Data 1 from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Jan Paul de Boer, Lisa Licitra et al.|Unknown|2025Cited by 0